Atorva TG

Zydus Lifesciences, formerly known as Cadila Healthcare, is a leading global pharmaceutical company headquartered in India. The company discovers, develops, manufactures, and markets a broad range of healthcare therapies, including small molecule generics, biologics, and vaccines. One of its notable commercial products is Atorva TG, a fixed-dose combination of atorvastatin and fenofibrate used to manage complex dyslipidemia by targeting both cholesterol and triglyceride levels. Zydus maintains a robust R&D pipeline focused on metabolic disorders, oncology, and inflammation, while operating extensive manufacturing facilities across India and the United States.